Finally, to assess the usefulness of salivary IgA measurement as a potential SLE biomarker, we generated receiver operating characteristic (ROC) curves to determine the discriminative capacity of salivary IgA subtypes (IgA1 or IgA2) concentration in SLE patients vs. healthy donors (Figure 5A). The gene discussed is CD79A; the disease is systemic lupus erythematosus.